Fresia Pareja, MD PhD, Assistant Attending, Department of Pathology and Laboratory Medicine Co-director of the Lobular Breast Cancer Program, Memorial Sloan Kettering Cancer Center, LBCA […]
LBCA: Tell us a little about your expertise, your ILC research, yourself, and why you think it is important to focus on lobular research? Dr.
Q&A with SAB Member Dr. Fresia Pareja Read More »
This year’s National Comprehensive Cancer Network® (NCCN®) Clinical Guidelines for Breast Cancer Treatment, Breast Cancer Screening and Diagnosis Guidelines, and Patient Guidelines on Invasive Breast
Q&A with Dr. Matt Covington: New Imaging Modalities Included in NCCN Guidelines Read More »
The Lobular Breast Cancer Alliance (LBCA) recently posed questions to Tali Amir, MD, about her recent study A role for breast ultrasound Artificial Intelligence decision
Q&A with Dr. Tali Amir: Using AI in the Imaging of ILC Read More »
By Andi K. Cani, PhD, University of Michigan Recent efforts to study the cellular changes driving breast cancer types have led to a better understanding
Tissue and Liquid Biopsies, Current Use and Promise in ILC Detection and Treatment Read More »
Study Author Discusses the Usefulness of the Breast Cancer Index in Assessing Risk of Lobular Breast Cancer Recurrence Invasive lobular carcinoma (ILC) is the second
LBCA Scientific Blog: Raquel Nunes, MD Read More »
LBCA Scientific Advisory Board Member Discusses Ongoing Clinical Research in ILC Breast cancer surgeons are often the first physicians to meet with patients after a
LBCA Scientific Blog: Rita Mukhtar, MD Read More »
The Lobular Breast Cancer Alliance (LBCA) collected questions about hormone therapy from women with lobular breast cancer, also known as invasive lobular carcinoma (ILC), and
Hormone Therapy Q&A with Dr. Rachel Jankowitz Read More »
LBCA Scientific Advisory Board Member Dr. Rebecca Riggins Discusses the Challenges of ILC-Specific Research and Potential Solutions In 2004, I was a new postdoctoral fellow
LBCA Scientific Blog: Rebecca Riggins, PhD Read More »
LBCA Scientific Advisor Dr. Gary Ulaner Describes Promising Methods in Clinical Trials for Better ILC Detection
LBCA Scientific Blog: Gary Ulaner, MD, PhD, FACNM Read More »
"*" indicates required fields